|
Parameter
|
Day
|
C
|
Hmix
|
Zn
|
Hmix+Zn
|
SD
|
Significance of effects
|
|---|
| | | | | | | |
Treatment
|
Time
|
Treatment × time
|
|---|
|
SAA
|
7
|
13.7
|
18.8
|
17.6
|
20.7
|
5.10
|
*
|
NS
|
*
|
|
(μg/mL)
|
35
|
17.9
|
15.4
|
23.7
|
14.2
|
5.20
| | | |
| |
49
|
17.9
|
16.9
|
22.9
|
18.6
|
4.12
| | | |
|
Calpro
|
7
|
49.1
|
49.1
|
48.5
|
44.7
|
4.70
|
NS
|
NS
|
NS
|
|
(ng/mL)
|
35
|
46.9
|
38.5
|
50.0
|
49.0
|
9.93
| | | |
| |
49
|
41.9
|
42.4
|
48.3
|
45.9
|
10.86
| | | |
|
IgA
|
7
|
0.287
|
0.234
|
0.328
|
0.211
|
0.0642
|
**
|
NS
|
NS
|
|
(mg/mL)
|
35
|
0.309
|
0.298
|
0.369
|
0.309
|
0.0572
| | | |
| |
49
|
0.224
|
0.315
|
0.360
|
0.204
|
0.0842
| | | |
| |
70
|
0.289
|
0.318
|
0.415
|
0.313
|
0.1124
| | | |
- C control, Hmix Herbmix, Zn Zn-glycinate, Hmix + Zn Herbmix and Zn-glycinate, NS not significant, SAA serum amyloid A, Calpro calprotectin, IgA immunoglobulin A
- * P < 0.05
